Drug delivery vehicles on a nano-engineering perspective

Autores
Felice, Betiana; Prabhakaran, Molamma P.; Rodriguez, Andrea Paola; Ramakrishna,Seeram
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.
Fil: Felice, Betiana. Universidad Nacional de Tucumán; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Prabhakaran, Molamma P.. National University Of Singapore; Singapur. Start Create; Singapur
Fil: Rodriguez, Andrea Paola. Universidad Nacional de Tucumán. Facultad de Ciencias Exactas y Tecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Ramakrishna,Seeram. National University Of Singapore; Singapur
Materia
Liposomes
Biodegradable Polymers
Cancer
Nanotechnology
Targeted Drug Delivery
Controlled Release
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/77081
Acceder
id CONICETDig_beff89790891baae6db3859b5cfc85a5
oai_identifier_str oai:ri.conicet.gov.ar:11336/77081
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Drug delivery vehicles on a nano-engineering perspectiveFelice, BetianaPrabhakaran, Molamma P.Rodriguez, Andrea PaolaRamakrishna,SeeramLiposomesBiodegradable PolymersCancerNanotechnologyTargeted Drug DeliveryControlled Releasehttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.Fil: Felice, Betiana. Universidad Nacional de Tucumán; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; ArgentinaFil: Prabhakaran, Molamma P.. National University Of Singapore; Singapur. Start Create; SingapurFil: Rodriguez, Andrea Paola. Universidad Nacional de Tucumán. Facultad de Ciencias Exactas y Tecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; ArgentinaFil: Ramakrishna,Seeram. National University Of Singapore; SingapurElsevier2014-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/77081Felice, Betiana; Prabhakaran, Molamma P.; Rodriguez, Andrea Paola; Ramakrishna,Seeram ; Drug delivery vehicles on a nano-engineering perspective; Elsevier; Material Science and Engineering: C; 41; 4-2014; 178-1950928-4931CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0928493114002410?via%3Dihubinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.msec.2014.04.049info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:53Zoai:ri.conicet.gov.ar:11336/77081instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:54.043CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Drug delivery vehicles on a nano-engineering perspective
title Drug delivery vehicles on a nano-engineering perspective
spellingShingle Drug delivery vehicles on a nano-engineering perspective
Felice, Betiana
Liposomes
Biodegradable Polymers
Cancer
Nanotechnology
Targeted Drug Delivery
Controlled Release
title_short Drug delivery vehicles on a nano-engineering perspective
title_full Drug delivery vehicles on a nano-engineering perspective
title_fullStr Drug delivery vehicles on a nano-engineering perspective
title_full_unstemmed Drug delivery vehicles on a nano-engineering perspective
title_sort Drug delivery vehicles on a nano-engineering perspective
dc.creator.none.fl_str_mv Felice, Betiana
Prabhakaran, Molamma P.
Rodriguez, Andrea Paola
Ramakrishna,Seeram
author Felice, Betiana
author_facet Felice, Betiana
Prabhakaran, Molamma P.
Rodriguez, Andrea Paola
Ramakrishna,Seeram
author_role author
author2 Prabhakaran, Molamma P.
Rodriguez, Andrea Paola
Ramakrishna,Seeram
author2_role author
author
author
dc.subject.none.fl_str_mv Liposomes
Biodegradable Polymers
Cancer
Nanotechnology
Targeted Drug Delivery
Controlled Release
topic Liposomes
Biodegradable Polymers
Cancer
Nanotechnology
Targeted Drug Delivery
Controlled Release
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.4
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.
Fil: Felice, Betiana. Universidad Nacional de Tucumán; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Prabhakaran, Molamma P.. National University Of Singapore; Singapur. Start Create; Singapur
Fil: Rodriguez, Andrea Paola. Universidad Nacional de Tucumán. Facultad de Ciencias Exactas y Tecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Investigaciones Biológicas. Universidad Nacional de Tucumán. Instituto Superior de Investigaciones Biológicas; Argentina
Fil: Ramakrishna,Seeram. National University Of Singapore; Singapur
description Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.
publishDate 2014
dc.date.none.fl_str_mv 2014-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/77081
Felice, Betiana; Prabhakaran, Molamma P.; Rodriguez, Andrea Paola; Ramakrishna,Seeram ; Drug delivery vehicles on a nano-engineering perspective; Elsevier; Material Science and Engineering: C; 41; 4-2014; 178-195
0928-4931
CONICET Digital
CONICET
url http://hdl.handle.net/11336/77081
identifier_str_mv Felice, Betiana; Prabhakaran, Molamma P.; Rodriguez, Andrea Paola; Ramakrishna,Seeram ; Drug delivery vehicles on a nano-engineering perspective; Elsevier; Material Science and Engineering: C; 41; 4-2014; 178-195
0928-4931
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0928493114002410?via%3Dihub
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.msec.2014.04.049
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269255826931712
score 13.13397

Publicaciones similares